TATVA IPO
IdeaForge lists at 94% above its IPO price
The previous best listing was by a speciality chemical company Tatva Chintan Pharma on July 29, 2021, which listed at a 95% premium over its issue price.
More than half of 2021 debutants giving positive returns, 5 still hold multibagger status
Out of 64 companies listed in 2021, 34 are trading above their respective issue prices, with at least six of them still trading more than 100 per cent above their issue price. However, despite this stellar performance, the debutants of last year have dropped between 13-72 per cent from their all time peaks, with 10 of them eroding more than one third of investors' wealth.
Tatva Chintan Pharma shares tumble 9% post Dec quarter earnings
The Ebitda declined 6 per cent to Rs 23 crore compared with Rs 25 crore posted last year. The company’s margin contracted to 22 per cent in the December 2021 quarter as against 32 per cent in the same period a year ago.
Stocks in the news: Go Fashion, PNB, Tatva Chintan, IRCTC and Reliance Capital
Go Fashion will make its Dalal Street Debut on Monday. The company sold its shares in the range of Rs 655-690 between November 17-22 to raise Rs 1,013.61 crore.
Whenever the market corrects, it would be deep, sharp and won’t give time to investors to exit: Rajat Sharma
“It is absolutely bonkers of a market where Nifty stocks continue to do well. There has to be a very strong reason for this market to fall but I can almost assure you that whenever that correction happens, it would be deep, sharp and it may not give time to many investors to move out of this market. The Indian market is unique that way.”
- Go To Page 1
Banks tap IPO investments, book listing gains
Banks are said to have substantially subscribed to recent issues such as Tatva Chintan Pharma, G R Infraprojects, Clean Science & Technology, Shyam Metalics, and Laxmi Organics. The qualified institutional buyers' portions in all these IPOs were subscribed between 150 times and 180 times. With a strong IPO pipeline, bank treasuries are expected to raise their stakes in equities.
India's richie rich will have to shell out more to be in the IPO league
With the spate of recent issues resulting in money getting locked up and funded bets made on the last two offerings resulting in losses, finance companies have increased rates by as much as 200 basis points or 2% for IPO loans.
IPOs raise over Rs 27,000 cr in Apr-Jul; issues worth Rs 70K cr in pipeline
According to an analysis of data available with the stock exchanges, 12 companies have raised Rs 27,052 crore through IPOs in the first four months (April-July) of the current fiscal 2021-22. Apart from these, PowerGrid InvIT, the infrastructure investment trust (InvIT) sponsored by the Power Grid Corporation of India, mopped up Rs 7,735 crore through its IPO.
Rolex Rings initial offer subscribed 130 times
The `731-crore initial public offering of Rolex Rings, an automotive component company, was subscribed 130 times on Friday— the last day of bidding.It received strong investor interest. The offer got bids for 74.15 crore shares against the issue size of 56.86 lakh shares.
Tatva Chintan surges over 100% on day 1
Tatva Chintan's first-day pop is among the strongest listings that the market has seen of late. Recently, food delivery platform Zomato listed at a 51% premium to its IPO price. GR Infraprojects and Clean Energy listed 105% and 98% above their IPO prices, respectively.
Tatva Chintan lists at 95% premium over issue price
The strong listing was in line with the recent trend, wherein market debutants have delivered 50-100 per cent returns at listing.
Will Tatva Chintan do a GR Infra on listing? Grey market says so
The grey market premium for the stock has surged to Rs 1,140-1,150 per share in the unofficial market, which can translate into 105-110 per cent premium over its price band of Rs 1,073-1,083.
Grey market premium hits crazy levels; time to turn cautious?
Dealers in the market in unlisted shares said grey market premium for Tatva Chintan Pharma Chem has jumped to Rs 1,140-1,150 over its price band of Rs 1,073-1,083, indicating a 105-110 per cent premium over the issue price.
Tatva Chintan set to become 2nd stock in July to double investor money on debut
The stock, whose listing is likely on Thursday, has seen its grey market premium (GMP) swell further to Rs 1,125 apiece from Rs 1,100 on Monday.
Tatva Chintan IPO allotment: Check GMP and application status
The basis of allotment for shares of Tatva Chintan is likely to be finalised by Monday, July 26. The shares of the company are expected to list on Thursday, July 29.
Tatva Chintan Pharma’s IPO subscribed 180 times
This is the second-best IPO so far this year in terms of investor demand. Earlier in March, the ₹596-crore IPO of MTAR Technologies was subscribed 201 times.
Tatva Chintan IPO subscribed 180.4 times on Day 3; GMP spikes to 70%
Tatva Chintan Pharma Chem has already received bids worth Rs 149.99 crore from 22 anchor investors at the upper price band of Rs 1,083 per equity share.
Tatva Chintan Pharma Chem IPO subscribed 15 times on Day 2
Tatva Chintan Pharma Chem has already received bids worth Rs 149.99 crore from 22 anchor investors at the upper price band of Rs 1,083 per equity share.
Grey market signals solid listing gains in GR Infra, Clean Science & Zomato
The grey market premia of Zomato and Tatva Chintan Pharma Chem (TCPC) -- whose IPO is still one -- also remain sturdy, signalling solid buying interest in the primary market.
Tatva Chintan Pharma Chem IPO subscribed 4.5 times on Day 1
Most analysts have advised investors to subscribe to the Rs 500 crore initial public offering (IPO). The price band of the issue has been fixed at Rs 1,073-1,083 a share. Bids can be made for a minimum of 13 shares and in multiples thereafter.
Tatva Chintan to use IPO proceeds for growth, not to repay debt: Chintan Shah
“We would continue to spend 2% to 3% of revenue on R&D and that would translate into a strong top line growth.”
Tatva Chintan Pharma Chem’s GMP rises to 64% as IPO opens
Most analysts have advised investors to subscribe to the Rs 500 crore initial public offering (IPO). The price band of the issue has been fixed at Rs 1,073-1,083 a share. Bids can be made for a minimum of 13 shares and in multiples thereafter.
Tatva Chintan’s valuation, high margins may attract investors
Long-term investors may subscribe to the IPO given the reasonable valuation, higher return ratios supported by tax holidays and rising proportion of chemicals with superior margin profiles.
Tatva Chintan Pharma Chem's Rs 500 cr IPO to open on July 16
The offer size is Rs 500 crore, of which the company will issue fresh equity shares worth Rs 225 crore and offer for sale by promoters and shareholders worth Rs 275 crore.
Chemplast Sanmar, Tatva Chintan Pharma Chem get Sebi nod for IPOs
Chemplast Sanmar and Tatva Chintan Pharma Chem obtained Sebi's observations on July 2 and June 30 respectively, an update with Sebi showed on Monday.
Sebi gives green signal to Zomato’s over $1 billion IPO
The approval comes after one of the largest shareholders in the company, Info Edge India, decided to cut its offer for sale (OFS) in the IPO to Rs. 375 crore from Rs. 750 crore earlier.
Load More
